Stock Market: Sensex down 1,100 points amid rising Covid cases

Gallery

MORE...

Sports

India Open Competition in Shotgun begins in Jaipur, paving way for Nationals' qualification

India Open Competition in Shotgun, organised by the National Rifle Association of India (N

Hockey India names Amir Ali-led 20-man team for Junior Asia Cup

Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award

World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17

U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals

FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup

MORE...

Stock Market: Sensex down 1,100 points amid rising Covid cases

Last Updated : 12 Apr 2021 11:02:29 AM IST

Stock Market: Sensex down 1,100 points amid rising Covid cases

The key Indian equity indices traded deep in the red on Monday morning with the BSE Sensex dropping around 1,100 points amid resurgent Covid cases across the country and concerns of localised lockdowns.

An across-the-board selloff was led by finance, banking, auto and metal stocks.

Around 10 a.m., Sensex was trading at 48,488.66, lower by 1,102.66 points or 2.22 per cent from its previous close of 49,591.32.

It opened at 48,956.65 and has so far recorded an intra-day high of 48,956.65 and a low of 48,112.17 points.

The Nifty50 on the National Stock Exchange (NSE) was trading at 14,494.40, lower by 340.45 points or 2.29 per cent from its previous close.

Manish Hathiramani, technical analyst with Deen Dayal Investments said: "The resistance of 14,950-15,000 has worked once again. The market has taken a severe u-turn and has tested the 14,300-14,400 support."

"For the markets to move up, we need to respect this support range and bounce up. 14,264 was the recent low recorded and if we break that, the next expected level is 13,900," he said.

The top losers on the Sensex were IndusInd Bank, Bajaj Finance and SBI, while the only gainers were Sun Pharmaceutical Industries and Infosys.